Published: Nov 28, 2023, 05:20 IST | Updated: Nov 28, 2023, 05:20 IST
For nearly 2 decades, China has been the preferred location for a range of pharmaceutical research and manufacturing services due to the low cost and speed offered by contract drugmakers there. But increasing geopolitical tensions with China is now prompting more companies to limit their reliance on Chinese contractors. China's loss is now India's advantage.